Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
12 11 Search
2026
Pharmacological Targets in Metabolic Diseases
2025
The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
Frontiers in Cellular and Infection Microbiology
2025
Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies
Biomedicines
2025
Gut microbiota’s role in heart failure
Heart Failure Reviews
2024
The impact of sodium-glucose cotransporter inhibitors on gut microbiota: a scoping review
Journal of Diabetes & Metabolic Disorders
2024
Exploring the mechanisms of chronic obstructive pulmonary disease and Crohn’s disease: a bioinformatics-based study
Scientific Reports
2024
20S-O-Glc-DM treats metabolic syndrome-induced heart failure through regulating gut flora
European Journal of Pharmacology
2023
Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin
Journal of Clinical Medicine
2023
Gut–Kidney–Heart: A Novel Trilogy
Biomedicines
2023
Effects and mechanisms of nutritional interventions on extradigestive complications in obese patients
World Journal of Gastrointestinal Surgery
2023
Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy
International Journal of Molecular Sciences
Additional cited-by details will be shown when available from Crossref